Search Results 521-530 of 2976 for ⚔[광고텔레:ADSFIX01] 바카라커뮤니티광고 대포장홍보 파워볼솔루션광고 개인장업체 카지노API 구글머니상홍보 노래방광고 토토디비광고 구글상단도배광고 상위노출대행⚔
The purpose of this study is to evaluate participants for immune responses and histological changes in the small bowel following 2 doses of TIMP-GLIA or placebo ...
About this study. The purpose of this study is to create a Mayo Clinic AUS research database with follow-up through 4 months. To eventually evaluate other ...
The purpose of this study is to assess the long-term safety, tolerability, and effectiveness of secukinumab over ustekinumab for the treatment of patients who ...
About this study. This randomized phase II/III trial studies how well temozolomide and veliparib work and compare them to temozolomide alone in treating ...
The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy ...
About this study. This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can ...
The purpose of this study is to determine the maximum tolerated dose (MTD), activity, and safety of oprozomib in patients with hematologic malignancies.
LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with ...
The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...
About this study. Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.